Search
for
Sort by
Research 61–90 of 188
- Dermatologic adverse events associated with chemotherapy and targeted anticancer therapy
- Cutaneous Drug Eruptions Associated with the Use of Biologies and Cutaneous Drug Eruptions Mimicking Specific Skin Diseases
- Repositioning Old Drugs for New Battles: The Expanding Role of Drug Repurposing in Cancer, Inflammation, and Metabolic Disease.
- Cutaneous Reactions to Drugs
- Cutaneous Side Effects of Chemotherapy and Radiotherapy
- A symphony of signals: the intricate role of lncRNAs in dermatological disorders
- Hair Graying: Mechanisms, Prevention, and Innovative Treatment Strategies – literature review
- Adverse Hair Reactions to New Targeted Therapies for Cancer
- Diuretics
- Melanocytes and Vitiligo (and Hair Graying)
- Primary cicatricial alopecias
- Cutaneous drug reactions
- Premature Hair Graying: Underlying Contributors and Management Approaches - An Updated Literature Review
- Upadacitinib in the treatment of a patient with the triad of atopic dermatitis, vitiligo, and alopecia areata: a case report and literature review
- Sexual dimorphism of COVID-19 inspires drug repositioning and host-targeting immunotherapy for viral pneumonia
- Real-world pharmacovigilance insights into drug-induced risk of alopecia
- MiRNA-24 downregulates KLF6 affecting STAT3 protein expression and phosphorylation regulating melanogenesis in cashmere goat coat
- Effects of local and systemic medications on eye health: Adverse reactions
- Impact of Chemotherapeutic Drug on People living with Cancer
- Manifestaciones dermatológicas en pacientes oncológicos pediátricos en un hospital de tercer nivel de Honduras
- Hair greying & its palliative management
- Hair Changes due to Drugs
- Poster Abstracts
- Index
- British Society for Dermatopathology
- Nilotinib-induced generalized keratosis pilaris: Report of a rare case
- Finasteride
- Tyrosine Kinase Inhibitors against Cancer: Their Safety in 216 Moroccan Patients
- Non-Rash Skin Toxicities Associated with Novel Targeted Therapies
- Dermatologic adverse events in pediatric patients receiving targeted anticancer therapies: A pooled analysis